| AGENDA |
| (The last 10-15 minutes of each session will be used for Q & A) |
| Thursday - April 4, 2013 |
Topic |
| 7:00 a.m. - 8:00 a.m. |
Breakfast/Exhibits |
|
| 8:00 a.m. - 8:05 a.m. |
Welcome
Donald Black, MD |
| 8:05 a.m. - 9:05 a.m. |
New Strategies for Treatment-Resistant Depression
Andrew A. Nierenberg, MD |
| 9:05 a.m. - 10:05 a.m. |
The Clinical Relevance of FDA “Black Box” Warnings
Henry Nasrallah, MD |
| 10:05 a.m. - 10:35 a.m. |
Break/Exhibits
|
|
| 10:35 a.m. - 11:35 a.m. |
What Have We Learned from Effectiveness Studies of Bipolar Disorder?
Andrew A. Nierenberg, MD |
| 11:35 a.m. - 12:35 p.m. |
Assessing a Psychotic Patient’s Risk of Violence
Rajiv Tandon, MD |
| 12:35 p.m. - 2:00 p.m.. |
Luncheon Symposium (Non-CME)
Exploring an ADHD Treatment Option
Michael Feld, MD (Northbrook, IL)
Sponsored by: Pfizer Inc.
|
|
| 2:00 p.m. - 2:15 p.m. |
Dessert/Exhibits |
|
| 2:15 p.m. - 3:15 p.m. |
Advances in Biomarkers of Alzheimer’s Disease and Other Cognitive Disorders
James Ellison, MD, MPH |
| 3:15 p.m. - 4:15 p.m. |
The Link Between Schizophrenia and Diabetes
Rajiv Tandon, MD |
| 4:15 p.m. - 4:35 p.m. |
Refreshment Break/Exhibits |
|
| 4:35 p.m. - 5:35 p.m. |
Mood Disorders in the Aging Patient
James Ellison, MD, MPH |
| 5:50 p.m. - 7:20 p.m. |
Dinner Symposium (Non-CME)
A New Once-Monthly Treatment Option for Your Patients with Schizophrenia
Mark N. Lerman, MD
Sponsored by: Otsuka America Pharmaceutical, Inc & Lundbeck |
| Friday - April 5, 2013 |
| 6:45 a.m. - 8:00 a.m. |
Breakfast Symposium (Additional 1.25 CME Credits)
The Neurotransmitter Conversation: Optimizing Outcomes for Patients With Treatment-Resistant Depression
Andrew A. Nierenberg, MD
Sponsored by the Neuroscience Education Institute.
Supported by an unrestricted educational grant from Mylan Specialty L.P. |
|
| 8:00 a.m. - 9:00 a.m. |
Update on Antipsychotic Use During Pregnancy
Marlene Freeman, MD |
| 9:00 a.m. - 10:00 a.m. |
From Dichotomy to Continuum: Clinical, Cognitive, Genetic, Neuroimaging and Pharmacological Overlap Between Schizophrenia and Bipolar Disorder
Henry A. Nasrallah, MD |
| 10:00 a.m. - 10:30 a.m. |
Break/Exhibits
|
|
| 10:30 a.m. - 11:30 a.m. |
Cognitive Enhancers: What the Evidence Says
George Grossberg, MD |
| 11:30 a.m. - 12:30 p.m. |
Nutrition and Vitamin Deficiencies in the Elderly
George Grossberg, MD |
| 12:30 p.m. - 2:00 p.m. |
Luncheon Symposium (non-CME)
Challenges and Opportunities in the Treatment of Schizophrenia
Roueen Rafeyan, MD
Peter Weiden, MD
Sponsored by Sunovion |
|
| 2:00 p.m. - 2:30 p.m. |
Dessert/Exhibits |
|
| 2:30 p.m. - 2:45 p.m. |
Winokur Award Presentation
|
|
| 2:45 p.m. - 3:45 p.m. |
Managing Anxiety Disorders During Pregnancy
Marlene Freeman, MD |
| 3:45 p.m. - 4:45 p.m. |
New Substances of Abuse: Bath Salts and Other Synthetics
Kathleen Brady MD, PhD |
| 4:45 p.m. - 5:00 p.m. |
Stretch Break
|
| 5:00 p.m. - 6:00 p.m. |
Treatment Strategies for Depression in Patients Abusing Alcohol
Kathleen Brady, MD, PhD |
| 6:15 p.m. |
Dinner Symposium (Additional 1.5 CME Credits)
Identifying Solutions to the Challenge of Non-adherence in Schizophrenia
Leslie Citrome, MD (Chair)
Ralph Aquila, MD
Supported by an educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck |
| Saturday - April 6, 2013 |
| 6:45 a.m. - 8:00 a.m. |
Breakfast Symposium (Additional 1.25 CME Credits)
Major Depressive Disorder: Effective Clinical Decisions
Andrew J. Cutler, MD
Sponsored by the Neuroscience Education Institute.
Supported by an unrestricted educational grant from Lundbeck and Takeda Pharmaceuticals International, Inc. |
|
| 8:00 a.m. - 9:00 a.m. |
Strategies for Treating Opioid Dependence
Walter Ling, MD |
| 9:00 a.m. - 10:00 a.m. |
Treating Bipolar Disorder in the Aging Patient
James Jefferson, MD |
| 10:00 a.m. - 10:15 a.m. |
Break |
|
| 10:15 a.m. - 11:15 a.m. |
Pharmacologic Treatment for Alcohol Dependence
Walter Ling, MD |
| 11:15 a.m. - 12:15 p.m. |
Best Practices in Suicide Risk Assessment
James Jefferson, MD |
| 12:15 p.m. - 1:45 p.m. |
Luncheon Symposium (Additional 1.5 CME Credits)
Advances in Bipolar Disorder: New Strategies for the Management of Bipolar Depression
Robert M.A. Hirschfeld, MD – Chairperson
Roger S. McIntyre, MD, FRCPC
Terence A. Ketter, MD
Jointly sponsored by Medical Education Resources and CMEology
Supported by an educational grant from Sunovion Pharmaceuticals, Inc.
|
|
| 2:00 p.m. |
Conference Adjournment |
|